Osteogenic differentiation of human marrow-derived mesenchymal stem cells (Q36804660)

16 August 2017

1 reference

title

Osteogenic differentiation of human marrow-derived mesenchymal stem cells (English)

1 reference

16 August 2017

Pierre J Marie

1

1 reference

16 August 2017

Olivia Fromigué

series ordinal

2

1 reference

16 August 2017

publication date

1 July 2006

1 reference

16 August 2017

published in

Regenerative Medicine

1 reference

16 August 2017

volume

1

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

539-548

1 reference

16 August 2017

cites work

Mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Marrow stromal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Isolation and characterization of osteoblast precursor cells from human bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Bone marrow stromal cells: characterization and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Development and Characterization of Conditionally Immortalized Osteoblast Precursor Cell Lines from Human Bone Marrow Stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Immortalization of Human Marrow Stromal Cells by Retroviral Transduction With a Temperature Sensitive Oncogene: Identification of Bipotential Precursor Cells Capable of Directed Differentiation to Either an Osteoblast or Adipocyte Phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1( ) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Human Trabecular Bone Cells Are Able to Express Both Osteoblastic and Adipocytic Phenotype: Implications for Osteopenic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Establishment of a rat long-term culture expressing the osteogenic phenotype: dependence on dexamethasone and FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Estrogen regulation of growth and alkaline phosphatase expression by cultured human bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Regulation of osteoblastogenesis and bone mass by Wnt10b

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

WNT and beta-catenin signalling: diseases and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Mesenchymal stem cells for bone gene therapy and tissue engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Adult mesenchymal stem cells and cell-based tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Mesenchymal stem cells: biological characteristics and potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Cell culture medium composition and translational adult bone marrow-derived stem cell research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Strong and rapid induction of osteoblast differentiation by Cbfa1/Til-1 overexpression for bone regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Assessment of gene regulation by bone morphogenetic protein 2 in human marrow stromal cells using gene array technology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

The profile of gene expression of human marrow mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

BMP2 gene therapy on the repair of bone defects of aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Biological approaches to bone regeneration by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Protein- and gene-based tissue engineering in bone repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

Canonical WNT Signaling Promotes Osteogenesis by Directly StimulatingRunx2Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217/17460751.1.4.539

21 January 2018

Identifiers

DOI

10.2217/17460751.1.4.539

1 reference

16 August 2017

1 reference